Defining correlates of protection for mammalian livestock vaccines against high-priority viral diseases

Front Immunol. 2024 Jul 19:15:1397780. doi: 10.3389/fimmu.2024.1397780. eCollection 2024.

Abstract

Enhancing livestock biosecurity is critical to safeguard the livelihoods of farmers, global and local economies, and food security. Vaccination is fundamental to the control and prevention of exotic and endemic high-priority infectious livestock diseases. Successful implementation of vaccination in a biosecurity plan is underpinned by a strong understanding of correlates of protection-those elements of the immune response that can reliably predict the level of protection from viral challenge. While correlates of protection have been successfully characterized for many human viral vaccines, for many high-priority livestock viral diseases, including African swine fever and foot and mouth disease, they remain largely uncharacterized. Current literature provides insights into potential correlates of protection that should be assessed during vaccine development for these high-priority mammalian livestock viral diseases. Establishment of correlates of protection for biosecurity purposes enables immune surveillance, rationale for vaccine development, and successful implementation of livestock vaccines as part of a biosecurity strategy.

Keywords: T cells; antibodies; biosecurity; correlates of protection; immunity; livestock; protection; vaccines.

Publication types

  • Review

MeSH terms

  • African Swine Fever / immunology
  • African Swine Fever / prevention & control
  • Animals
  • Foot-and-Mouth Disease / immunology
  • Foot-and-Mouth Disease / prevention & control
  • Humans
  • Livestock* / immunology
  • Livestock* / virology
  • Swine
  • Vaccination* / veterinary
  • Viral Vaccines* / immunology
  • Virus Diseases / immunology
  • Virus Diseases / prevention & control
  • Virus Diseases / veterinary

Substances

  • Viral Vaccines

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was funded by the CSIRO Immune Resilience Future Science Platform (IR-FSP).